methylphenidate
Showing 1 - 25 of 166
Methylphenidate Treatment in ADHD
Not yet recruiting
- Methylphenidate
- Metabolomics
- methylphenidate
- (no location specified)
Oct 6, 2023
ADHD Trial in Baltimore (Methylphenidate, Placebo)
Not yet recruiting
- ADHD
- Methylphenidate
- Placebo
-
Baltimore, MarylandJohns Hopkins School of Medicine
Oct 5, 2023
Substance Use Disorder, Cocaine Use Disorder Trial in New York (Methylphenidate, Memory reconsolidation, Placebo)
Recruiting
- Substance Use Disorder
- Cocaine Use Disorder
- Methylphenidate
- +2 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Jul 28, 2023
Parkinson Disease, Apathy Trial (Psychosocial intervention, Methylphenidate)
Not yet recruiting
- Parkinson Disease
- Apathy
- Psychosocial intervention
- Methylphenidate
- (no location specified)
Dec 28, 2022
Mechanism of Action of Methylphenidate in ADHD
Not yet recruiting
- Attention Deficit Hyperactivity Disorder
- Methylphenidate
- (no location specified)
Oct 26, 2022
PTSD (PTSD) Trial in Tuscaloosa, Seattle (Methylphenidate, Placebo)
Not yet recruiting
- Posttraumatic Stress Disorder (PTSD)
- Methylphenidate
- Placebo
-
Tuscaloosa, Alabama
- +1 more
Mar 8, 2023
Attention Deficit Disorder With Hyperactivity, Diabetes, Type 1 Trial (parental training in behavior management,
Not yet recruiting
- Attention Deficit Disorder With Hyperactivity
- Diabetes Mellitus, Type 1
- parental training in behavior management
- +2 more
- (no location specified)
Jul 19, 2023
Pain Trial in Chicago (Methylphenidate, Placebo)
Recruiting
- Pain
- Methylphenidate
- Placebo
-
Chicago, IllinoisNorthwestern University
Dec 30, 2022
Healthy Volunteers Trial in Lille (Methylphenidate, Placebo, CogniPlus software)
Recruiting
- Healthy Volunteers
- Methylphenidate
- +3 more
-
Lille, FranceHôpital Roger Salengro, CHU
Aug 16, 2022
Alcohol Use Disorder Trial in Lexington (Alcohol, Placebos, Duloxetine)
Recruiting
- Alcohol Use Disorder
- Alcohol
- +3 more
-
Lexington, KentuckyUniversity of Kentucky
Sep 23, 2022
ADHD - Combined Type Trial in Baltimore (Methylphenidate, Placebo)
Recruiting
- ADHD - Combined Type
- Methylphenidate
- Placebo
-
Baltimore, MarylandJohns Hopkins School of Medicine
May 12, 2022
PTSD Trial in Haifa, Netanya (Methylphenidate, Reboxetine, Placebo)
Recruiting
- Posttraumatic Stress Disorder
- Methylphenidate
- +2 more
-
Haifa, Israel
- +1 more
Nov 20, 2022
Advanced Malignant Tumor, Metastatic Malignant Tumor, Recurrent Malignant Tumor Trial in Houston (Laboratory Biomarker Analysis,
Active, not recruiting
- Advanced Malignant Neoplasm
- +2 more
- Laboratory Biomarker Analysis
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Dec 13, 2022
Prostate Carcinoma Trial in Houston (behavioral, drug, other)
Recruiting
- Prostate Carcinoma
- Exercise Intervention
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Sep 21, 2022
Fatigue Trial in Houston (Methylphenidate, Fatigue Evaluations)
Completed
- Fatigue
- Methylphenidate
- Fatigue Evaluations
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jan 3, 2022
ADHD, ADHD Trial in United States (Methylphenidate)
Recruiting
- ADHD
- Attention Deficit Hyperactivity Disorder
- Methylphenidate
-
Gainesville, Florida
- +3 more
Apr 5, 2022
PTSD, Stroke Trial in Birmingham (Methylphenidate, Placebo)
Recruiting
- PTSD
- Stroke
- Methylphenidate
- Placebo
-
Birmingham, AlabamaBirmingham VA Medical Center, Birmingham, AL
Jan 18, 2022
Fatigue, Cancer Trial in Houston (Methylphenidate, Placebo (Sugar Pill))
Completed
- Fatigue
- Cancer
- Methylphenidate
- Placebo (Sugar Pill)
-
Houston, TexasM D Anderson Cancer Center
Dec 16, 2021
Alzheimer, Apathy in Dementia Trial in Toronto (rTMS, methylphenidate)
Recruiting
- Alzheimer Disease
- Apathy in Dementia
- rTMS
- methylphenidate
-
Toronto, Ontario, CanadaSunnybrook Health Sciences Centre
Sep 29, 2022
Parkinson's Disease, Idiopathic Trial in Cleveland (Methylphenidate, Physical Therapy, Atomoxetine)
Recruiting
- Parkinson's Disease, Idiopathic
- Methylphenidate
- +2 more
-
Cleveland, OhioCleveland Clinic
Feb 15, 2022
Chronic Pain Trial in Rochester (Methylphenidate, carbidopa-levodopa, Placebo)
Recruiting
- Chronic Pain
- Methylphenidate
- +2 more
-
Rochester, New YorkUniversity of Rochester Medical Center
Jan 9, 2023
Neurodevelopmental Disorders, Cerebral Palsy Trial in Kuwait (Methylphenidate, Modafinil, Placebo)
Not yet recruiting
- Neurodevelopmental Disorders
- Cerebral Palsy
- Methylphenidate
- +2 more
-
Kuwait, KuwaitPhysical Medicine and Rehabilitation Hospital
Dec 21, 2022
Methamphetamine Use Disorder Trial in Lexington (Methamphetamine, Methylphenidate, Placebo oral capsule)
Completed
- Methamphetamine Use Disorder
- Methamphetamine
- +3 more
-
Lexington, Kentucky
- +1 more
Jan 14, 2022
ADHD Trial in Roma (Methylphenidate, anodal tDCS, sham tDCS)
Active, not recruiting
- Attention Deficit Hyperactivity Disorder
- Methylphenidate
- +2 more
-
Roma, ItalyBambino Gesù Hospital and Research Institute
Jul 26, 2022
Advanced Cancer, Fatigue Trial in Houston (Methylphenidate, Nursing Telephone Intervention, Placebo)
Completed
- Advanced Cancer
- Fatigue
- Methylphenidate
- +3 more
-
Houston, Texas
- +1 more
Dec 16, 2021